Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Little Green Pharma medicinal cannabis
- Development stage
- Unknown
- Lead developer
- Little Green Pharma
- Modality
- Small Molecules
- Administration
- Oral, Sublingual, Inhalation
01
Overview
Little Green Pharma medicinal cannabis is a range of pharmaceutical-grade, plant-derived cannabinoid products developed by the Australian company Little Green Pharma Ltd. These products are primarily whole-plant extracts formulated as oral oils or flower, containing varying ratios of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). They are designed to interact with the human endocannabinoid system, specifically targeting the CB1 and CB2 receptors to provide therapeutic benefits for chronic conditions. The range is prescribed under the Australian Therapeutic Goods Administration (TGA) Special Access Scheme (SAS) or Authorised Prescriber pathways for indications including chronic pain, neuropathic pain, cancer-related symptoms, multiple sclerosis-associated spasticity, and refractory epilepsy. The company also utilizes a proprietary liposomal delivery technology designed to improve the bioavailability of its cannabinoid formulations.
- Brand names
- Little Green Pharma
- Other names
- LGP medicinal cannabisLGP cannabis oil
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Little Green Pharma medicinal cannabis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Little Green Pharma medicinal cannabis.